Cargando…
Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review
AIM: Changes in strategies in the coronavirus disease 2019 (COVID-19) crisis and the imposing of restrictions have isolated many vulnerable patients including those with hepatocellular carcinoma (HCC) from routine medical care. This study investigated how the COVID-19 pandemic is affecting the diagn...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651356/ https://www.ncbi.nlm.nih.gov/pubmed/38023991 http://dx.doi.org/10.37349/etat.2023.00179 |
_version_ | 1785135978573201408 |
---|---|
author | Mazidimoradi, Afrooz Sabet Birjandi, Samane Salehiniya, Hamid |
author_facet | Mazidimoradi, Afrooz Sabet Birjandi, Samane Salehiniya, Hamid |
author_sort | Mazidimoradi, Afrooz |
collection | PubMed |
description | AIM: Changes in strategies in the coronavirus disease 2019 (COVID-19) crisis and the imposing of restrictions have isolated many vulnerable patients including those with hepatocellular carcinoma (HCC) from routine medical care. This study investigated how the COVID-19 pandemic is affecting the diagnosis and treatment of HCC. METHODS: An extensive search was conducted in the PubMed, Scopus, and Web of Science databases by using the appropriate keywords: COVID-19, hepatocellular carcinoma, hepatocellular cancer, and MeSH. Studies in English related to the purpose of the study were included in the analysis, and review studies, case reports, letters to editors, comments, and reports were excluded. The quality of the studies was assessed by the “Adapted Newcastle-Ottawa Quality Assessment Scales” checklist. The Endnote X7 software has been used for managing items. RESULTS: The final qualitative analysis consisted of 27 articles. During the COVID-19 crisis, HCC diagnosis decreased from 20% to 34.13% compared to pre-crisis. The impact of the COVID-19 pandemic on HCC treatment encompasses a wide range of aspects. Generally, delays in treatment for patients with HCC ranged from more than one month for 21.5% of patients in France, to two months for 26% of patients in Italy, up to 30% in Austria, and 66.7% in Asia-Pacific countries. CONCLUSIONS: According to the findings, developing and implementing appropriate diagnostic and therapeutic strategies and developing low-cost and high-precision screening programs among high-risk populations seem to be effective in reducing the impact of the COVID-19 pandemic on HCC management. |
format | Online Article Text |
id | pubmed-10651356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Open Exploration Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106513562023-10-26 Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review Mazidimoradi, Afrooz Sabet Birjandi, Samane Salehiniya, Hamid Explor Target Antitumor Ther Systematic Review AIM: Changes in strategies in the coronavirus disease 2019 (COVID-19) crisis and the imposing of restrictions have isolated many vulnerable patients including those with hepatocellular carcinoma (HCC) from routine medical care. This study investigated how the COVID-19 pandemic is affecting the diagnosis and treatment of HCC. METHODS: An extensive search was conducted in the PubMed, Scopus, and Web of Science databases by using the appropriate keywords: COVID-19, hepatocellular carcinoma, hepatocellular cancer, and MeSH. Studies in English related to the purpose of the study were included in the analysis, and review studies, case reports, letters to editors, comments, and reports were excluded. The quality of the studies was assessed by the “Adapted Newcastle-Ottawa Quality Assessment Scales” checklist. The Endnote X7 software has been used for managing items. RESULTS: The final qualitative analysis consisted of 27 articles. During the COVID-19 crisis, HCC diagnosis decreased from 20% to 34.13% compared to pre-crisis. The impact of the COVID-19 pandemic on HCC treatment encompasses a wide range of aspects. Generally, delays in treatment for patients with HCC ranged from more than one month for 21.5% of patients in France, to two months for 26% of patients in Italy, up to 30% in Austria, and 66.7% in Asia-Pacific countries. CONCLUSIONS: According to the findings, developing and implementing appropriate diagnostic and therapeutic strategies and developing low-cost and high-precision screening programs among high-risk populations seem to be effective in reducing the impact of the COVID-19 pandemic on HCC management. Open Exploration Publishing 2023 2023-10-26 /pmc/articles/PMC10651356/ /pubmed/38023991 http://dx.doi.org/10.37349/etat.2023.00179 Text en © The Author(s) 2023. https://creativecommons.org/licenses/by/4.0/This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Systematic Review Mazidimoradi, Afrooz Sabet Birjandi, Samane Salehiniya, Hamid Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review |
title | Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review |
title_full | Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review |
title_fullStr | Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review |
title_full_unstemmed | Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review |
title_short | Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review |
title_sort | effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651356/ https://www.ncbi.nlm.nih.gov/pubmed/38023991 http://dx.doi.org/10.37349/etat.2023.00179 |
work_keys_str_mv | AT mazidimoradiafrooz effectofcoronavirusdisease2019ondiagnosisandtreatmentofhepatocellularcarcinomaasystematicreview AT sabetbirjandisamane effectofcoronavirusdisease2019ondiagnosisandtreatmentofhepatocellularcarcinomaasystematicreview AT salehiniyahamid effectofcoronavirusdisease2019ondiagnosisandtreatmentofhepatocellularcarcinomaasystematicreview |